Cite
Which Batch Size for Validation and Stability Studies? Process validation for a drug product must be done with commercial scale batches, says Siegfried Schmitt, vice president, Technical at Parexel.
MLA
Schmitt, Siegfried. “Which Batch Size for Validation and Stability Studies? Process Validation for a Drug Product Must Be Done with Commercial Scale Batches, Says Siegfried Schmitt, Vice President, Technical at Parexel.” BioPharm International, vol. 35, no. 5, May 2022, pp. 50–49. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=156697220&authtype=sso&custid=ns315887.
APA
Schmitt, S. (2022). Which Batch Size for Validation and Stability Studies? Process validation for a drug product must be done with commercial scale batches, says Siegfried Schmitt, vice president, Technical at Parexel. BioPharm International, 35(5), 50–49.
Chicago
Schmitt, Siegfried. 2022. “Which Batch Size for Validation and Stability Studies? Process Validation for a Drug Product Must Be Done with Commercial Scale Batches, Says Siegfried Schmitt, Vice President, Technical at Parexel.” BioPharm International 35 (5): 50–49. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=156697220&authtype=sso&custid=ns315887.